13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001213900-24-068546
Total Value
$1.08B
Positions
42
Other Managers
0
Confidential Omitted
No
Holdings (42)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Soleno Therapeutics Inc | SLNO | 7,316,851 | $298.5M | 27.58% |
| 2 | Geron Corp | GERN | 27,225,292 | $115.4M | 10.66% |
| 3 | Harmony Biosciences Holdings Inc | HRMY | 2,606,247 | $78.6M | 7.26% |
| 4 | Sinovac Biotech Ltd. | SVA | 11,800,000 | $76.3M | 7.05% |
| 5 | Dyne Therapeutics Inc | DYN | 1,635,136 | $57.7M | 5.33% |
| 6 | Avadel Pharmaceuticals PLC | 05337M104 | 3,972,099 | $55.8M | 5.16% |
| 7 | Verona Pharma PLC | 925050106 | 3,549,758 | $51.3M | 4.74% |
| 8 | Terns Pharmaceuticals Inc | TERN | 6,182,992 | $42.1M | 3.89% |
| 9 | ALX Oncology Holdings Inc | ALXO | 4,220,048 | $25.4M | 2.35% |
| 10 | Viridian Therapeutics Inc | VRDN | 1,678,207 | $21.8M | 2.02% |
| 11 | Astria Therapeutics Inc | 04635X102 | 2,329,027 | $21.2M | 1.96% |
| 12 | Silence Therapeutics PLC | SLNCF | 1,105,454 | $21.0M | 1.94% |
| 13 | Olema Pharmaceuticals Inc | OLMA | 1,873,704 | $20.3M | 1.87% |
| 14 | Cogent Biosciences Inc | COGT | 2,244,941 | $18.9M | 1.75% |
| 15 | Erasca Inc | ERAS | 6,756,756 | $15.9M | 1.47% |
| 16 | Tarsus Pharmaceuticals Inc | TARS | 565,550 | $15.4M | 1.42% |
| 17 | Delcath Systems, Inc. | DCTH | 1,666,746 | $14.0M | 1.29% |
| 18 | Rezolute Inc | RZLT | 2,797,704 | $12.0M | 1.11% |
| 19 | Celcuity Inc | CELC | 610,500 | $10.0M | 0.92% |
| 20 | Sera Prognostics Inc | SERA | 1,650,440 | $9.8M | 0.90% |
| 21 | Compass Pathway PLC | CMPS | 1,608,000 | $9.7M | 0.90% |
| 22 | Zai Lab Ltd | ZLAB | 531,198 | $9.2M | 0.85% |
| 23 | Oric Pharmaceuticals Inc | ORIC | 1,269,676 | $9.0M | 0.83% |
| 24 | Regulus Therapeutics Inc | 75915K309 | 5,000,000 | $8.9M | 0.82% |
| 25 | Abeona Therapeutics, Inc. | ABEO | 1,842,751 | $7.8M | 0.72% |
| 26 | Tourmaline Bio Inc. | 89157D105 | 591,882 | $7.6M | 0.70% |
| 27 | Corbus Pharmaceuticals Holdings | CRBP | 166,794 | $7.5M | 0.70% |
| 28 | IO Biotech Inc | IOBT | 6,173,439 | $7.2M | 0.67% |
| 29 | Instil Bio Inc | TIL | 624,339 | $6.4M | 0.59% |
| 30 | Engene Holdings Inc. | ENGNW | 678,705 | $6.4M | 0.59% |
| 31 | Verastem Inc | VSTM | 1,538,461 | $4.6M | 0.42% |
| 32 | Compass Therapeutics Inc | CMPX | 3,556,023 | $3.6M | 0.33% |
| 33 | Allakos Inc | 01671P100 | 2,988,000 | $3.0M | 0.28% |
| 34 | Bolt Therapeutics Inc | BOLT | 3,521,291 | $2.6M | 0.24% |
| 35 | Unicycive Therapeutics | UNCY | 3,470,152 | $1.7M | 0.16% |
| 36 | Aligos Therapeutics Inc | ALGS | 3,547,030 | $1.2M | 0.11% |
| 37 | Codexis, Inc | CDXS | 388,144 | $1.2M | 0.11% |
| 38 | DBV Technologies SA | DBVTF | 1,354,437 | $1.1M | 0.10% |
| 39 | Adverum Biotechnologies, Inc. | 00773U207 | 833,333 | $833,333 | 0.08% |
| 40 | Aadi Bioscience Inc | WHWK | 509,572 | $743,975 | 0.07% |
| 41 | Q32 Bio Inc. | QTTB | 20,559 | $369,034 | 0.03% |
| 42 | Precision Biosciences Inc | DTIL | 4,675 | $45,489 | 0.00% |